BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2001
View Archived Issues
Gilead launches Viread this week in U.S.
Read More
Preliminary findings reported at AACR-NCI-EORTC from ongoing phase I studies of new GARFT inhibitor
Read More
Active Biotech commences phase II trials of MS treatment
Read More
MediChem receives SBIR grant for topoisomerase I inhibitors
Read More
Preclinical data support clinical development of XR-5944 and XR-11576
Read More
NN-622 development continues without Novartis
Read More
MedImmune licenses rights to cancer targets
Read More
Inex c-myc antisense oligonucleotide well tolerated in phase I study in combination with cisplatin
Read More
Medivir compound targeting multiresistant HIV enters phase IIa trial
Read More
Two vaccines for HPV prove effective in clinical trials
Read More
Zelmac receives Swiss approval for treatment of IBS
Read More
Positive interaction demonstrated between PI-88 and several cytotoxic agents in animal tumor model
Read More
Therion secures financing to advance lead cancer vaccine into phase III trials
Read More
Remitogen and Rituxan assessed in combination in cancer patients
Read More
AACR-NCI-EORTC news: little severe toxicity seen in dose-escalating trial of IL-2 mutein
Read More
Esperion offers brief update of Q3 developments
Read More
Orally active KDR tyrosine kinase inhibitor effective in spontaneously metastatic human tumor model
Read More
Corvas updates rNAPc2 development and reviews progress in cancer programs
Read More
Phase I study results for NV-06 presented by Australian investigators in Miami Beach
Read More
Chimeric bikunin molecule shown to suppress ovarian cancer cell migration and invasion
Read More
Microcarriers enhance brain cancer gene therapy efficacy
Read More
New potassium channel openers and uses thereof reported by Abbott team
Read More
Ariad designs new series of Src kinase SH2 antagonists
Read More
Nonemetogenic PDE4 inhibitors result from R&D at Inflazyme
Read More
New imidazoles jointly described by Novo Nordisk and Boehringer Ingelheim as H3 ligands
Read More
Benzimidazoles and benzotriazoles as chemokine receptor modulators
Read More
Aventis identifies cannabinoid CB1 receptor antagonists
Read More
Inhibitors of hormone-sensitive lipase (HSL) useful in diabetes and related disorders
Read More
